Clinical Significance of Placenta Previa Detected at Early Routine Transvaginal Scan

Size: px
Start display at page:

Download "Clinical Significance of Placenta Previa Detected at Early Routine Transvaginal Scan"

Transcription

1 Clinical Significance of Placenta Previa Detected at Early Routine Transvaginal Scan Paolo Rosati, MD, Lorenzo Guariglia, MD Transvaginal ultrasonography in early pregnancy was used to determine the prevalence of placenta previa and the rate of persistence until delivery. The location of the placenta was registered systematically in 2342 pregnant women who underwent transvaginal ultrasonography at 10 to 16 weeks gestation as a primary examination. The outcome of pregnancy as well as the presence or absence of placenta previa at delivery was noted in a total of 2158 cases. A receiver operating characteristic curve was generated for the different measurements from the edge of the placenta to the internal cervical os versus placenta previa at delivery. In 105 of the 2158 women screened in the early stages of pregnancy (4.9%) the placenta extended to or over the internal P lacenta previa leads to increased maternal and fetal morbidity, caused primarily by hemorrhage, particularly in undiagnosed ABBREVIATIONS TVS, Transvaginal sonography; ICO, Internal cervical os; ROC, Receiver operating characteristic; CI, Confidence interval; SD, Standard deviation; PPV, Positive predictive value; NPV, Negative predictive value Received January 13, 2000, from the Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy. Revised manuscript accepted for publication May 4, This study was supported by grants No CT04 from the Italian Council of Research (CNR) and No from the Ministry of University and Scientific and Technological Research (MURST). Address correspondence and reprint requests to Paolo Rosati, MD, Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Largo A. Gemelli, Rome, Italy. cervical os, and in 34 of 2158 patients (1.6%) the distance to the placental edge beyond the internal cervical os was equal to or greater than 14 mm. Of the eight cases of placenta previa at delivery, six (75%) were identified in our study, and two cases were missed. When a cutoff value of greater than 14 mm is used for the receiver operating characteristic curve the likelihood is 17.6% (95% confidence interval = 6.8 to 34.5) for placenta previa at delivery. Although a high percentage of false-positive results occur owing to the low prevalence at delivery, this screening procedure can identify high-risk patients who should be rescanned later in pregnancy. KEY WORDS: Placenta previa; Pregnancy, early; Ultrasonography, transvaginal. cases. 1,2 Thus, an accurate and early diagnosis of placenta previa would be important and useful in clinical obstetrical practice. Recently, with the introduction of high-frequency TVS, earlier and safer visualization of the lower placental edge and the ICO is possible by the transabdominal route, 3,4 and therefore a more timely and accurate diagnosis of placenta previa is feasible. The aims of the present study were to evaluate retrospectively (1) the ability to predict in early pregnancy, using TVS, the risk of placenta previa at delivery and (2) the usefulness of an early assessment of placental location in relation to the ICO and its implications for the normal evolution of pregnancy. In addition, we examined whether the distance the placenta extended over the ICO had clinical significance by the American Institute of Ultrasound in Medicine J Ultrasound Med 19: , /00/$3.50

2 582 PLACENTA PREVIA AT EARLY SCANNING J Ultrasound Med 19: , 2000 SUBJECTS AND METHODS During the period April 1995 through February 1999, a cross-sectional study of TVS examinations in 2342 pregnant patients with a live singleton fetus between 10 and 16 weeks gestation was performed. The reasons for referral of patients were advanced maternal age (73.7%), family history of chromosomal or morphologic abnormalities (14.7%), abnormal results of second trimester maternal serum screening for fetal aneuploidy (5.1%), and other indications (6.5%). In addition to fetal measurements and morphologic evaluation, the location of the placenta was registered systematically, and in cases of placental extension to or over the ICO, the distance from the edge of the placenta to the ICO was measured. When the placenta did not reach the ICO, the distance of the nearest placental edge to the ICO was also measured, and a negative measurement was assigned. These cases are not considered for the study. Placental position (anterior or posterior) also was recorded. Excluded from the study were 184 patients: 151 cases were lost to follow-up, 9 elected termination of pregnancy elsewhere on maternal request, and 24 resulted in spontaneous abortion. The pregnancy outcome and the presence or absence of placenta previa at delivery were determined in 2158 cases. The mean age of the patients was 32.1 years (range, 16 to 44 years); 53% of the mothers were nulliparous, whereas 34% had one and 13% had two or more previous births. In order to evaluate the reproducibility of the measurements, 40 patients were studied by two independent observers (P.R., L.G.), and the differences in measurements were calculated for each case. All of the patients had three different consecutive measurements of the distance from the edge of the placenta to the ICO taken by each sonographer, who was unaware of the results obtained by the other. The interobserver and intraobserver coefficient of variation were calculated. Sonographic examinations were performed using a high-resolution apparatus (model SSA-270 A and SSA-340 A; Toshiba Medical Corporation, Tokyo, Japan) equipped with 5.0 to 7.0 MHz transvaginal probes with a maximal angle of vision of 86 degrees and 121 degrees, respectively. All the scans were performed by the authors (60% by P.R., 40% by L.G.). The patients were examined in a supine lithotomy position with an empty bladder. The lower edge of the placenta and the ICO were identified with the probe placed in the anterior fornix of the vagina. The measurements were obtained with electronic calipers, and in each case two measurements were performed, of which the shorter was used. Placenta previa was defined as the presence of a placenta extending to or over the ICO; the condition was considered marginal if the distance to the placental edge beyond the ICO was 10 mm or less at ultrasonographic examination, and as total if the distance was greater than 10 mm. An ROC curve was generated for the different measurements from the edge of the placenta to the ICO versus placenta previa at delivery and is provided to allow assessment of cutoff values that meet sensitivity and specificity requirements. A cutoff value was chosen that maximized the sensitivity while minimizing the false positive rate (1- specificity). 5 Statistical analysis to compare the placental location (anterior versus posterior) was obtained using the chi-square test, with statistical significance of differences assigned at P < Binomial exact 95% CI values were calculated using Stata 6.0 software (Stata, College Station, TX). RESULTS The presence of placental extension to or over the ICO was diagnosed in a total of 105 women (4.9%) among the 2158 patients who underwent early transvaginal scanning. The prevalence was 6.4% at 10 weeks gestation and diminished to 4.3% at 16 weeks gestation but was fairly constant between 12 and 15 weeks gestation with a value of about 5%. In 58 cases (55.2%) the placenta was anterior and in 47 (44.8%) it was posterior. This difference was not statistically significant. In 69 cases (65.7%) the placenta previa was defined as marginal, and in 36 cases (34.3%) it was categorized as total. Of the 69 cases with a TVS diagnosis of marginal placenta previa, only one was associated with a bleeding episode prior to term; this case would have been diagnosed regardless and was confirmed at the cesarean delivery. The mean values of interobserver and intraobserver measurements (± SD) for the location of the placenta over the ICO were 0.8 ± 0.4 and 0.7 ± 0.4, respectively, and the coefficient of variation was 0.5% and 0.6%, respectively. Eight of the 2158 women (0.37%) had placenta previa at delivery, and two cases were undiagnosed by early transvaginal scan (Table 1). The diagnosis of placenta previa was confirmed in all eight cases by ultrasonographic examination performed in the third trimester of pregnancy. The ROC curve generated from the various measurements of the placental edge extending over the

3 J Ultrasound Med 19: , 2000 ROSATI AND GUARIGLIA 583 Table 1: Placental Characteristics and Pregnancy Outcome Screening Outcome GA at TVS Extension of Placenta Initial Bleeding GA at Delivery Mode of Type of (weeks) Over ICO (mm) Episode (GA) (weeks) Delivery Placenta Previa CD Total CD Total CD Total CD Marginal CD Marginal CD Total CD Marginal 15.3 * CD Marginal GA, Gestational age; CD, cesarean delivery. *Posterior placenta not extending over the ICO. ICO shows 14 mm as the most efficient cutoff point optimizing both sensitivity and specificity (Fig. 1). With a cutoff value of 14 mm, 34 of the 105 patients (32.4%) in whom the placenta extended to or over the ICO at TVS were screen-positive, and 6 had a placenta previa found at delivery (17.6%; 95% CI = 6.8 to 34.5). With a cutoff value of 12 mm, 42 patients (40%) were screen-positive, and 14.3% (6/42; 95% CI = 5.4 to 28.5) of cases persisted to delivery. With a cutoff value of 16 mm, 27 patients (25.7%) were screen-positive, and 4 had placenta previa at delivery (14.8%; 95% CI = 4.2 to 33.7) (Table 2). DISCUSSION In our study, performed between 10 and 16 weeks gestation, 4.9% of the women screened revealed a placenta that extended to or over the ICO. These data are slightly less than those reported by Hill and coworkers 6 and by Taipale and colleagues 7 for the same gestation period of 9 to 13 weeks, and they are higher than those reported by Lauria and coauthors 8 and by Taipale and associates 9 for midpregnancy by either transvaginal or transabdominal ultrasonography. These results reporting a higher prevalence at 9 to 13 weeks gestation may possibly be attributed to the rate of the placental migration, since from the fourth month until delivery the placenta grows more slowly than the uterus, 10,11 and the development of the lower uterine segment is more rapid than that of the uterine fundus. Because of this phenomenon, Townsend and coworkers 12 preferred the terminology differential lower uterine segment/placental growth rate to describe changes in the position of the placenta. Subsequently, the development of the lower uterine segment permitted a vaginal delivery in over 90% of cases diagnosed as associated with placenta previa by a second trimester sonographic examination, 11 further supporting a high false-positive rate for placenta previa when early placental location is used. Moreover, placental migration also occurs in the first half of pregnancy. Taipale and colleagues 7 reported a prevalence of placenta previa by transvaginal scanning of 5.5% at 12 to 13 weeks of gestation, which decreased to 2.4% at 15 to 16 weeks gestation. Placental migration from the region of Figure 1 ROC curve generated for placenta previa at delivery in 105 patients with the placenta edge extending to or over the ICO with different cutoff points (in millimeters) at screening. A cutoff value was chosen that maximized the sensitivity while minimizing the false-positive rate (1-specificity).

4 584 PLACENTA PREVIA AT EARLY SCANNING J Ultrasound Med 19: , 2000 Table 2: Placenta Previa Observed at 10 to 16 Weeks Transvaginal Screening (105 Cases) in Predicting Placenta Previa at Delivery Placental Edge over the ICO at TVS 12 mm 14 mm 16 mm Variable n/n % (95% CI) n/n % (95% CI) n/n % (95% CI) Sensitivity 6/ (41.1, 99.6) 6/ (42.1, 99.6) 4/ (18.4, 90.1) Specificity 62/ (52.9, 72.8) 70/ (61.4, 80.1) 75/ (66.9, 94.5) PPV 6/ (5.4, 28.5) 6/ (6.8, 34.5) 4/ (4.2, 33.7) NPV 62/ (91.5, 99.9) 70/ (92.4, 99.9) 75/ (89.2, 99.2) the ICO occurred at a variable rate that was not always related to the degree to which the placenta covered the ICO. In some cases a marked change in placental location was noted between the first and second trimesters, whereas in other cases the ICO region was not free of the placenta until the third trimester. 6 In our study, the percentage of the placenta that covered the ICO remained quite similar between 11 and 15 weeks gestation. The different prevalence rates for low-lying placenta observed with transabdominal versus transvaginal scanning not only are related to the gestational age at which the sonographic examination was performed but also reflect attention to scanning technique. In fact, higher false-positive rates of placenta previa are found with the transabdominal than with the transvaginal technique and may possibly be due to an overdistended bladder, uterine contractions, or poor visualization. 8,13 In our study, if at 10 to 16 weeks gestation the edge of the placenta extended for at least 14 mm over the ICO, the PPV of placenta previa at delivery was 17.6% (95% CI = 6.8 to 34.5). This cutoff point was quite similar to that previously reported by Hill and coworkers 6 at 9 to 13 weeks gestation and by Taipale and colleagues 7 at 12 to 16 weeks gestation. In addition, the risk of placenta previa at delivery in our study was similar to the 20% reported by Hill and coauthors 6 but higher than the 5.1% and 4.6% reported by Taipale and coworkers 7 and Zelop and associates, 14 respectively. A higher risk of 18.5% in predicting placenta previa at delivery was also described by Taipale and associates9 when transvaginal sonography was performed at 18 to 23 weeks gestation. The prevalence of placenta previa at delivery ranged from 1.5 to 6.0 per 1000 births. 2,3,8,9,11,13,15,16 In our study, placenta previa occurred at delivery in 1 of 270 cases (0.37%), data similar to those reported in a large epidemiological study 13 but greater when compared to other recent studies of a low-risk population. 8,9 Furthermore, racial, genetic, age, and parity differences 2,13,17 may exist in the prevalence of placenta previa. The findings of our study indicate that, by transvaginal scanning at 10 to 16 weeks gestation and using a 14 mm overlap as the cutoff point, 75% of the cases of placenta previa at delivery were identified. In two cases placenta previa was present at delivery, but the placental edge covering the ICO was less than 14 mm at screening. Finally, of the total number of the cases in which the distance to the placental edge beyond the ICO was equal or greater than 14 mm, the likelihood was that only 17.6% (95% CI = 6.8 to 34.5) will result in a clinical placenta previa at delivery. Notwithstanding, despite the high percentage of false-positive results related to the low prevalence of this pathologic condition at delivery, the precise location of the placenta as diagnosed by early transvaginal scan could be considered to be the first, accurate prediction of patients at risk for placenta previa. Placenta previa is frequently revealed with bleeding episodes prior to term, which facilitates a diagnosis, but it may be asymptomatic 14 and appear as a sudden catastrophic hemorrhage or bleeding as the pregnancy approaches term, putting both the mother and fetus at increased risk for a poor outcome. 18 Since, in our experience, the measure of placental extension diagnosed by TVS remained fairly constant from 12 to 15 weeks gestation, an early TVS at this particular period of pregnancy could provide a useful criterion for diagnosing cases of possible placenta previa that would need an ultrasonographic reexamination in the third trimester of pregnancy.

5 J Ultrasound Med 19: , 2000 ROSATI AND GUARIGLIA 585 REFERENCES 1. Meshame PM, Heye PS, Epstein MF: Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol 65:176, Gorodeski IG, Bahari CM: The effect of placenta previa localization upon maternal and fetal-neonatal outcome. J Perinat Med 15:167, Chapman MG, Furness ET, Jones WR, et al: Significance of the ultrasound location of placenta site in early pregnancy. Br J Obstet Gynaecol 86:846, Timor-Tritsch IE, Yunis RA: Confirming the safety of transvaginal sonography in patients suspected of placenta previa. Obstet Gynecol 81,742, Richardson DK, Schwartz JS, Weinbaum PJ, et al: Diagnostic test in obstetrics: A method for improved evaluation. Am J Obstet Gynecol 152:613, Hill LM, Di Nofrio DM, Chenevey P: Transvaginal sonographic evaluation of first-trimester placenta previa. Ultrasound Obstet Gynecol 5:30, Taipale P, Hilesmaa V, Ylostalo P: Diagnosis of placenta previa by transvaginal sonographic screening at weeks in a non selected population. Obstet Gynecol 89:364, Lauria MR, Smith RS, Treadwell MC, et al: The use of second-trimester transvaginal sonography to predict placenta previa. Ultrasound Obstet Gynecol 8:337, Taipale P, Hiilesmaa V, Ylostalo P: Transvaginal ultrasonography at weeks in predicting placenta previa at delivery. Ultrasound Obstet Gynecol 12:422, King DL: Placental migration demonstrated by ultrasonography. Radiology 109:167, Rizos N, Doran TA, Miskin M, et al: Natural history op placenta previa ascertain by diagnostic ultrasound. Am J Obstet Gynecol 133:287, Townsend RR, Laing FC, Nyberg DA, et al: Technical factors responsible for placental migration : Sonographic assessment. Radiology 160:105, Iyasu S, Saftlas AK, Rowley DL, et al: The epidemiology of placenta previa in the United States, 1979 through Am J Obstet Gynecol 168:1424, Zelop CC, Bromley B, Frigoletto FD, et al: Second trimester sonographically diagnosed placenta previa: Prediction of persistent previa at birth. Int J Gynecol Obstet 44:207, Mills JL, Graubard BI, Klebanoff MA: Association of placenta previa and sex ratio at birth. Br Med J 294:544, Saari-Kemppainen A, Karjalainen O, Ylostalo P, et al: Ultrasound screening and perinatal mortality: Controlled trial of systematic one-stage screening in pregnancy. Lancet 336:38, Rose GL: Aetiological factors in placenta preavia: A case controlled study. Br J Obstet Gynaecol 93:586, Iyasu S, Saftlas AK, Rowley DL, et al: The epidemiology of placenta previa in the United States, 1979 through Am J Obstet Gynecol 168:1424, 1993

Prognosis of Very Large First-Trimester Hematomas

Prognosis of Very Large First-Trimester Hematomas Case Series Prognosis of Very Large First-Trimester Hematomas Juliana Leite, MD, Pamela Ross, RDMS, RDCS, A. Cristina Rossi, MD, Philippe Jeanty, MD, PhD Objective. The aim of this study was to evaluate

More information

What is the diagnostic value of ultrasound for determining a viable intrauterine pregnancy?

What is the diagnostic value of ultrasound for determining a viable intrauterine pregnancy? What is the diagnostic value of ultrasound for determining a viable intrauterine pregnancy? Full citation Sample size Tests Methods Results Limitations Steinkampf,M.P., Guzick,D.S., Hammond,K.R., Blackwell,R.E.,

More information

Evaluation and Follow-up of Fetal Hydronephrosis

Evaluation and Follow-up of Fetal Hydronephrosis Evaluation and Follow-up of Fetal Hydronephrosis Deborah M. Feldman, MD, Marvalyn DeCambre, MD, Erin Kong, Adam Borgida, MD, Mujgan Jamil, MBBS, Patrick McKenna, MD, James F. X. Egan, MD Objective. To

More information

Clinical Significance of First Trimester Umbilical Cord Cysts

Clinical Significance of First Trimester Umbilical Cord Cysts Clinical Significance of First Trimester Umbilical Cord Cysts Waldo Sepulveda, MD, Sergio Leible, MD, Angel Ulloa, MD, Milenko Ivankovic, MD, Carlos Schnapp, MD A cystic mass of the umbilical cord was

More information

First-Trimester Cesarean Scar Pregnancy Evolving Into Placenta Previa/Accreta at Term

First-Trimester Cesarean Scar Pregnancy Evolving Into Placenta Previa/Accreta at Term Case Report First-Trimester Cesarean Scar Pregnancy Evolving Into Placenta Previa/Accreta at Term Jara Ben Nagi, MD, Dede Ofili-Yebovi, MD, Mike Marsh, MD, Davor Jurkovic, MD Placenta accreta is a rare

More information

Assessment of Fetal Growth

Assessment of Fetal Growth Assessment of Fetal Growth Unit / Trust: 1. INTRODUCTION The aim of this guideline template is to outline the methods used to assess fetal growth and the referral pathways utilising customised antenatal

More information

Placenta Accreta: Clinical Risk Factors, Accuracy of Antenatal Diagnosis and Effect on Pregnancy Outcome

Placenta Accreta: Clinical Risk Factors, Accuracy of Antenatal Diagnosis and Effect on Pregnancy Outcome ORIGINAL ARTICLE Placenta Accreta: Clinical Risk Factors, Accuracy of Antenatal Diagnosis and Effect on Pregnancy Outcome S Sofiah, MMed*, Late Y C Fung, FRCOG** *Department of O & G, Medical Faculty,

More information

Placenta, Cord, & Fluid

Placenta, Cord, & Fluid , Cord, & Fluid Abruption Accreta/Increta/Percreta Chorioangioma Complete Partial Not generally Relevant to U/S Gestational Age (Weeks) Distance from 16-23.9 24 to Internal Os >20 mm No No 11-20 mm 0-10

More information

A. Evidence for an individually adjustable standard to assess birth weight:

A. Evidence for an individually adjustable standard to assess birth weight: Customised antenatal growth charts are designed to facilitate better supervision of fetal growth. The chart is printed out in early pregnancy, after confirmation of pregnancy dates, and allows serial plotting

More information

Free Echogenic Pelvic Fluid: Correlation with Hemoperitoneum

Free Echogenic Pelvic Fluid: Correlation with Hemoperitoneum Free Echogenic Pelvic Fluid: Correlation with Hemoperitoneum G. Kimberly Sickler, MD, Phebe C. Chen, MD, Theodore J. Dubinsky, MD, Nabil Maklad, MD, PhD Echogenic fluid is an important extrauterine finding

More information

Differentiation between normal and abnormal fetal growth

Differentiation between normal and abnormal fetal growth Differentiation between normal and abnormal fetal growth JASON GARDOSI MD FRCSE FRCOG Director, West Midlands Perinatal Institute, St Chad s Court, 213 Hagley Road, Birmingham B16 9RG, U.K. Tel +44 (0)121

More information

Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions

Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in * (MBChB, FICMS, CABOG) **Sawsan Talib Salman (MBChB, FICMS, CABOG) ***Huda Khaleel Ibrahim (MBChB) Abstract Background: - Although

More information

Screening Asymptomatic Women for Ovarian Cancer: American College of Preventive Medicine Practice Policy Statement

Screening Asymptomatic Women for Ovarian Cancer: American College of Preventive Medicine Practice Policy Statement ATTENTION This Policy was reaffirmed by the ACPM Board of Regents on 1/31/2005 and is effective through 1/31/2010. Screening Asymptomatic Women for Ovarian Cancer: American College of Preventive Medicine

More information

Eastern Mediterranean Health Journal, Vol. 10, No. 3, 2004 437

Eastern Mediterranean Health Journal, Vol. 10, No. 3, 2004 437 Eastern Mediterranean Health Journal, Vol. 10, No. 3, 2004 437 Report Normal uterine size in women of reproductive age in northern Islamic Republic of Iran S. Esmaelzadeh, 1 N. Rezaei 1 and M. HajiAhmadi

More information

A single center experience with 1000 consecutive cases of multifetal pregnancy reduction

A single center experience with 1000 consecutive cases of multifetal pregnancy reduction A single center experience with 1000 consecutive cases of multifetal pregnancy reduction Joanne Stone, MD, Keith Eddleman, MD, Lauren Lynch, MD, and Richard L. Berkowitz, MD New York, NY, and San Juan,

More information

Clinical Studies Abstract Booklet

Clinical Studies Abstract Booklet Clinical Studies Abstract Booklet The Harmony Prenatal Test is a non-invasive prenatal test (NIPT) that assesses the risk of trisomies by analyzing cell-free DNA (cfdna) in maternal blood. Since January

More information

Diagnosis and Management of Placenta Previa

Diagnosis and Management of Placenta Previa SOGC CLINICAL PRACTICE GUIDELINE No. 189, March 2007 Diagnosis and Management of Placenta Previa This guideline has been reviewed by the Clinical Obstetrics Committee and approved by the Executive and

More information

Charts of fetal size: limb bones

Charts of fetal size: limb bones BJOG: an International Journal of Obstetrics and Gynaecology August 2002, Vol. 109, pp. 919 929 Charts of fetal size: limb bones Lyn S. Chitty a, *, Douglas G. Altman b Objective To construct new size

More information

Maternity Care Primary C-Section Rate Specifications 2014 (07/01/2013 to 06/30/2014 Dates of Service)

Maternity Care Primary C-Section Rate Specifications 2014 (07/01/2013 to 06/30/2014 Dates of Service) Summary of Changes Denominator Changes: Two additions were made to the denominator criteria. The denominator was changed to include patients who had: a vertex position delivery AND a term pregnancy of

More information

Article. Anthony O. Odibo, MD, Christopher Riddick, Emmanuelle Pare, MD, David M. Stamilio, MD, MSCE, George A. Macones, MD, MSCE

Article. Anthony O. Odibo, MD, Christopher Riddick, Emmanuelle Pare, MD, David M. Stamilio, MD, MSCE, George A. Macones, MD, MSCE Article Cerebroplacental Doppler Ratio and Adverse Perinatal Outcomes in Intrauterine Growth Restriction Evaluating the Impact of Using Gestational Age Specific Reference Values Anthony O. Odibo, MD, Christopher

More information

REPRODUCTIVE ENDOCRINOLOGY

REPRODUCTIVE ENDOCRINOLOGY FERTILITY AND STERILITY VOL. 82, NO. 5, NOVEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. REPRODUCTIVE ENDOCRINOLOGY

More information

Fetal Prognosis in Varix of the Intrafetal Umbilical Vein

Fetal Prognosis in Varix of the Intrafetal Umbilical Vein Fetal Prognosis in Varix of the Intrafetal Umbilical Vein Waldo Sepulveda, MD, Antonio Mackenna, MD, Jorge Sanchez, MD, Edgardo Corral, MD, Eduardo Carstens, MD To assess the clinical significance of varix

More information

Effect of Increased Body Mass Index on the Accuracy of Estimated Fetal Weight by Sonography in Twins

Effect of Increased Body Mass Index on the Accuracy of Estimated Fetal Weight by Sonography in Twins Article Effect of Increased Body Mass Index on the Accuracy of Estimated Fetal Weight by Sonography in Twins Manisha Gandhi, MD, Lauren Ferrara, MD, Victoria Belogolovkin, MD, Erin Moshier, MS, Andrei

More information

Estimation of Fetal Weight: Mean Value from Multiple Formulas

Estimation of Fetal Weight: Mean Value from Multiple Formulas Estimation of Fetal Weight: Mean Value from Multiple Formulas Michael G. Pinette, MD, Yuqun Pan, MD, Sheila G. Pinette, RPA-C, Jacquelyn Blackstone, DO, John Garrett, Angelina Cartin Mean fetal weight

More information

Sonographic Accuracy of Estimated Fetal Weight in Twins

Sonographic Accuracy of Estimated Fetal Weight in Twins ORIGINAL RESEARCH Sonographic Accuracy of Estimated Fetal Weight in Twins Lorie M. Harper, MD, MSCI, Kimberly A. Roehl, MPH, Methodius G. Tuuli, MD, MPH, Anthony O. Odibo, MD, MSCE, Alison G. Cahill, MD,

More information

Sonographic screening for trisomy 13 at 11 to 13 D6 weeks of gestation

Sonographic screening for trisomy 13 at 11 to 13 D6 weeks of gestation American Journal of Obstetrics and Gynecology (2006) 194, 397 401 www.ajog.org Sonographic screening for trisomy 13 at 11 to 13 D6 weeks of gestation Aris T. Papageorghiou, MD, a Kyriaki Avgidou, MD, a

More information

Sonographic Evaluation of the Lower Uterine Segment in Patients With Previous Cesarean Delivery

Sonographic Evaluation of the Lower Uterine Segment in Patients With Previous Cesarean Delivery Article Sonographic Evaluation of the Lower Uterine Segment in Patients With Previous Cesarean Delivery Vincent Y. T. Cheung, MBBS, FRCOG, FRCSC, RDMS, Oana C. Constantinescu, MD, RDMS, Birinder S. Ahluwalia,

More information

GYNAECOLOGY. Ahmed Mohamed Abbas*, Mohamed Khalaf*, Abd El-Aziz E. Tammam**, Ahmed H. Abdellah**, Ahmed Mwafy**. Introduction ABSTRACT

GYNAECOLOGY. Ahmed Mohamed Abbas*, Mohamed Khalaf*, Abd El-Aziz E. Tammam**, Ahmed H. Abdellah**, Ahmed Mwafy**. Introduction ABSTRACT Thai Journal of Obstetrics and Gynaecology April 2015, Vol. 23, pp. 113-117 GYNAECOLOGY The Diagnostic Value of Saline Infusion Sonohysterography Versus Hysteroscopy in Evaluation of Uterine Cavity in

More information

echocardiography practice and try to determine the ability of each primary indication to identify congenital heart disease. Patients and Methods

echocardiography practice and try to determine the ability of each primary indication to identify congenital heart disease. Patients and Methods 29 ABNORMAL CARDIAC FINDINGS IN PRENATAL SONOGRAPHIC EXAMINATION: AN IMPORTANT INDICATION FOR FETAL ECHOCARDIOGRAPHY? RIMA SAMI BADER Aim: The present study was conducted to evaluate the most common indications

More information

Crohn's disease and pregnancy.

Crohn's disease and pregnancy. Gut, 1984, 25, 52-56 Crohn's disease and pregnancy. R KHOSLA, C P WILLOUGHBY, AND D P JEWELL From the Gastroenterology Unit, Radcliffe Infirmary, Oxford SUMMARY Infertility and the outcome of pregnancy

More information

The value of ultrasound in the prediction of successful induction of labor

The value of ultrasound in the prediction of successful induction of labor Ultrasound Obstet Gynecol 2004; 24: 538 549 Published online 27 August 2004 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.1100 The value of ultrasound in the prediction of successful

More information

Ultrasonography of the Fetal Thyroid

Ultrasonography of the Fetal Thyroid Article Ultrasonography of the Fetal Thyroid Nomograms Based on Biparietal Diameter and Gestational Age Angela C. Ranzini, MD, Cande V. Ananth, PhD, MPH, John C. Smulian, MD, MPH, Michelle Kung, Anita

More information

Bladder Injury during Cesarean Section: A Case Control Study for 10 Years

Bladder Injury during Cesarean Section: A Case Control Study for 10 Years Bahrain Medical Bulletin, Vol., No., September Bladder Injury during Cesarean Section: A Case Control Study for Years Mesfer Al-Shahrani, MD, FRCSC* Objective: To determine the incidence, risk factors

More information

Fetal Lateral Ventricular Width: What Should Be Its Upper Limit?

Fetal Lateral Ventricular Width: What Should Be Its Upper Limit? Article Fetal Lateral Ventricular Width: What Should Be Its Upper Limit? A Prospective Cohort Study and Reanalysis of the Current and Previous Data Benny Almog, MD, Ronni Gamzu, MD, PhD, Reuven Achiron,

More information

Intrauterine sonographic assessments of embryonic heart diameter

Intrauterine sonographic assessments of embryonic heart diameter Human Reproduction vol.12 no.10 pp.2286 2291, 1997 Intrauterine sonographic assessments of embryonic heart diameter Toshiyuki Hata 1, Daisaku Senoh, Kohkichi Hata and Kohji Miyazaki Department of Obstetrics

More information

CONFIDENT CODING FOR OB/GYN CONFIDENT CODING FOR OB/GYN

CONFIDENT CODING FOR OB/GYN CONFIDENT CODING FOR OB/GYN Arlene J. Smith, CPC AAPC National Advisory Board 2007-2009 1 So when exactly does the global period start? Unraveling the confusion in antepartum care coding Correct coding for multiple gestations! Vaginal

More information

Ultrasonographic Evaluation of the Cervix

Ultrasonographic Evaluation of the Cervix Ultrasonographic Evaluation of the Cervix Transperineal Versus Endovaginal Imaging Barbara S. Hertzberg, MD, Elizabeth Livingston, MD, David M. DeLong, PhD, Patricia J. McNally, RDMS, Constance K. Fazekas,

More information

Use of Ultrasound in the Provision of Abortion. Juan E. Vargas, MD Assistant Professor of Clinical Obstetrics and Gynecology and Radiology, UCSF

Use of Ultrasound in the Provision of Abortion. Juan E. Vargas, MD Assistant Professor of Clinical Obstetrics and Gynecology and Radiology, UCSF Use of Ultrasound in the Provision of Abortion Juan E. Vargas, MD Assistant Professor of Clinical Obstetrics and Gynecology and Radiology, UCSF Overview Uses and indications of ultrasound in the provision

More information

Cornual ruptured pregnancy with placenta increta CORNUAL RUPTURED PREGNANCY WITH PLACENTA INCRETA A RARE CASE

Cornual ruptured pregnancy with placenta increta CORNUAL RUPTURED PREGNANCY WITH PLACENTA INCRETA A RARE CASE 142 CORNUAL RUPTURED PREGNANCY WITH PLACENTA INCRETA A RARE CASE Agarwal NR 1, Rani A 1 *, Batra S 1 1. Department of Obststetrics and Gynaecology, Institute of Medical Sciences, Banares Hindu Univarsity.

More information

fi АУ : fi apple Ав Ав АУ . apple, АУ fiав Ав. АК applefi АУ, АУАв Ав fi АУ apple fi Ав. А applefi АУ АУ АУ АсА» Ас Ам, длappleapple Ас...

fi АУ : fi apple Ав Ав АУ . apple, АУ fiав Ав. АК applefi АУ, АУАв Ав fi АУ apple fi Ав. А applefi АУ АУ АУ АсА» Ас Ам, длappleapple Ас... АВАВАКдлАмА дла длама АсАядлАмА АВА АсдлАя & MАядлдлАмАК TА. 4, T. 2, АВ. 113-118, 2005 fi АУ : Аяapplefi. fiapple АсА» Ас Ам, длappleapple Ас..., Ая: Аяapplefi. fiapple, АВАУ Ас, АсА» Ас Ам длappleapple

More information

Doppler Ultrasound in the Management of Fetal Growth Restriction Chukwuma I. Onyeije, M.D. Atlanta Perinatal Associates

Doppler Ultrasound in the Management of Fetal Growth Restriction Chukwuma I. Onyeije, M.D. Atlanta Perinatal Associates Doppler Ultrasound in the Management of Fetal Growth Restriction Chukwuma I. Onyeije, M.D. Atlanta Perinatal Associates 1 For your convenience a copy of this lecture is available for review and download

More information

Clinical Policy: Ultrasound in Pregnancy Reference Number: CP.MP.38

Clinical Policy: Ultrasound in Pregnancy Reference Number: CP.MP.38 Clinical Policy: Reference Number: CP.MP.38 Effective Date: 02/11 Last Review Date: 08/15 Revision Log Coding Implications See Important Reminder at the end of this policy for important regulatory and

More information

Migration of an intrauterine contraceptive device to the sigmoid colon: a case report

Migration of an intrauterine contraceptive device to the sigmoid colon: a case report The European Journal of Contraception and Reproductive Health Care 2003;8:229 232 Case Report Migration of an intrauterine contraceptive device to the sigmoid colon: a case report Ü. S. nceboz, H. T. Özçakir,

More information

Preterm Labor, the Cervix, and Progesterone. The Cervix. The Cervix. Disclosure of Conflict of Interest. 2nd Trimester Cervical Length

Preterm Labor, the Cervix, and Progesterone. The Cervix. The Cervix. Disclosure of Conflict of Interest. 2nd Trimester Cervical Length Disclosure of Conflict of Interest Preterm Labor, the Cervix, and Progesterone John C. Hobbins, M.D. Professor of Obstetrics and Gynecology University of Colorado Health Sciences Center Denver, CO Dr.

More information

Umbilical Artery Doppler Waveform Indices in Normal Pregnancies

Umbilical Artery Doppler Waveform Indices in Normal Pregnancies Thai Journal of Obstetrics and Gynaecology June 2000, Vol. 12, pp. 103-107 OBSTETRICS Umbilical Artery Doppler Waveform Indices in Normal Pregnancies Pharuhas Chanprapaph MD, Chanane Wanapirak MD, Theera

More information

First Trimester Screening for Down Syndrome

First Trimester Screening for Down Syndrome First Trimester Screening for Down Syndrome What is first trimester risk assessment for Down syndrome? First trimester screening for Down syndrome, also known as nuchal translucency screening, is a test

More information

Non-Invasive Prenatal Testing (NIPT) Factsheet

Non-Invasive Prenatal Testing (NIPT) Factsheet Introduction NIPT, which analyzes cell-free fetal DNA circulating in maternal blood, is a new option in the prenatal screening and testing paradigm for trisomy 21 and a few other fetal chromosomal aneuploidies.

More information

Acute pelvic inflammatory disease: tests and treatment

Acute pelvic inflammatory disease: tests and treatment Acute pelvic inflammatory disease: tests and treatment Information for you Information for you Published August 2010 Published in August 2010 (next review date: 2014) Acute What is pelvic inflammatory

More information

Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience

Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience ACTA BIOMED 2007; 78: 214-219 Mattioli 1885 O R I G I N A L A R T I C L E Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years

More information

THE LABOUR ADMISSION CTG An assessment of the test s predictive values, reliability and effect How the test is perceived by practicing midwives

THE LABOUR ADMISSION CTG An assessment of the test s predictive values, reliability and effect How the test is perceived by practicing midwives THE LABOUR ADMISSION CTG An assessment of the test s predictive values, reliability and effect How the test is perceived by practicing midwives Ellen Blix Doctoral thesis at the Nordic School of Public

More information

Long-Term Prognosis of Pregnancies Complicated by Slow Embryonic Heart Rates in the Early First Trimester

Long-Term Prognosis of Pregnancies Complicated by Slow Embryonic Heart Rates in the Early First Trimester Long-Term Prognosis of Pregnancies Complicated by Slow Embryonic Heart Rates in the Early First Trimester Peter M. Doubilet, MD, PhD, Carol B. Benson, MD, Jeanne S. Chow, MD Slow embryonic heart rates

More information

Screening for chromosomal abnormalities at 10 14 weeks: the role of ductus venosus blood flow

Screening for chromosomal abnormalities at 10 14 weeks: the role of ductus venosus blood flow Ultrasound Obstet Gynecol 1998;12:380 384 Screening for chromosomal abnormalities at 10 14 weeks: the role of ductus venosus blood flow A. Matias*, C. Gomes*, N. Flack*, N. Montenegro and K. H. Nicolaides*

More information

Epidemiology, trends in use of Cesarean section

Epidemiology, trends in use of Cesarean section February, 2010 Source Michelangelo Epidemiology, trends in use of Cesarean section Siri Vangen National Resource Centre for Women s Health, Department of Obstetric and Gynaecology, Oslo University Hospital

More information

Strategies for the Prevention of Prematurity Progesterone. Cervical Screening, Cerclage, and Pessaries

Strategies for the Prevention of Prematurity Progesterone. Cervical Screening, Cerclage, and Pessaries Strategies for the Prevention of Prematurity Progesterone. Cervical Screening, Cerclage, and Pessaries Thomas J. Garite, M.D. Professor Emeritus, University of CA Irvine Editor Emeritus, American Journal

More information

SWISS SOCIETY OF NEONATOLOGY. Umbilical cord complications in two subsequent pregnancies

SWISS SOCIETY OF NEONATOLOGY. Umbilical cord complications in two subsequent pregnancies SWISS SOCIETY OF NEONATOLOGY Umbilical cord complications in two subsequent pregnancies June 2006 2 Hetzel PG, Godi E, Bührer C, Department of Neonatology (HPG, BC), University Children s Hospital, Basel,

More information

Information for you A low-lying placenta (placenta praevia) after 20 weeks

Information for you A low-lying placenta (placenta praevia) after 20 weeks Information for you A low-lying placenta (placenta praevia) after 20 weeks Published in December 2011 Who is this information for? This information is intended to help you if you have, or have been told

More information

Prenatal screening and diagnostic tests

Prenatal screening and diagnostic tests Prenatal screening and diagnostic tests Contents Introduction 3 First trimester routine tests in the mother 3 Testing for health conditions in the baby 4 Why would you have a prenatal test? 6 What are

More information

Reference values for umbilical cord diameters in placenta specimens

Reference values for umbilical cord diameters in placenta specimens 1 2 3 Reference values for umbilical cord diameters in placenta specimens H. Pinar 1, Murat Iyigün 2 4 5 6 7 8 9 10 Halit Pinar, MD Brown Medical School Women and Infants Hospital Division of Perinatal

More information

In This Issue: Summer 2012. Tell Us What You Think... 1

In This Issue: Summer 2012. Tell Us What You Think... 1 Summer 2012 Important information from UnitedHealthcare Community Plan for physicians and other health care professionals and facilities serving New Jersey FamilyCare/Medicaid members Physician Satisfaction

More information

The National Down Syndrome Cytogenetic Register for England and Wales: 2008/9 Annual Report

The National Down Syndrome Cytogenetic Register for England and Wales: 2008/9 Annual Report 0 The National Down Syndrome Cytogenetic Register for England and Wales: 2008/9 Annual Report Joan K Morris, Elizabeth De Souza December 2009 National Down Syndrome Cytogenetic Register Queen Mary University

More information

EFFECT OF INCREASED TESTOSTERONE LEVEL ON WOMAN S FERTILITY

EFFECT OF INCREASED TESTOSTERONE LEVEL ON WOMAN S FERTILITY 1 Nada Polyclinic, Po ega, Croatia 2 School of Medicine, University of Zagreb, Zagreb, Croatia Preliminary Communication Received: April 15, 2004 Accepted: June 16, 2004 EFFECT OF INCREASED TESTOSTERONE

More information

Diagnostic Accuracy of Sonographic Criteria for Evaluation of Cervical Lymphadenopathy

Diagnostic Accuracy of Sonographic Criteria for Evaluation of Cervical Lymphadenopathy Diagnostic Accuracy of Sonographic Criteria for Evaluation of Cervical Lymphadenopathy Michael Ying, MPhil, Anil Ahuja, FRCR, Constantine Metreweli, FRCR Although ultrasonographic criteria for abnormal

More information

CAR Standard for Performing Diagnostic Obstetric Ultrasound Examinations

CAR Standard for Performing Diagnostic Obstetric Ultrasound Examinations CAR Standard for Performing Diagnostic Obstetric Ultrasound Examinations The standards of the Canadian Association of Radiologists (CAR) are not rules, but are guidelines that attempt to define principles

More information

Umbilical Arterial Blood Gas and Perinatal Outcome in the Second Twin according to the Planned Mode of Delivery

Umbilical Arterial Blood Gas and Perinatal Outcome in the Second Twin according to the Planned Mode of Delivery 643 Ivyspring International Publisher Research Paper International Journal of Medical Sciences 2011; 8(8):643-648 Umbilical Arterial Blood Gas and Perinatal Outcome in the Second Twin according to the

More information

AUSTRALIA AND NEW ZEALAND FACTSHEET

AUSTRALIA AND NEW ZEALAND FACTSHEET AUSTRALIA AND NEW ZEALAND FACTSHEET What is Stillbirth? In Australia and New Zealand, stillbirth is the death of a baby before or during birth, from the 20 th week of pregnancy onwards, or 400 grams birthweight.

More information

Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free β-hcg and PAPP-A at 11 + 0to13+ 6 weeks

Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free β-hcg and PAPP-A at 11 + 0to13+ 6 weeks Ultrasound Obstet Gynecol 2006; 27: 151 155 Published online 30 December 2005 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.2699 Screening for trisomy 21 by fetal tricuspid regurgitation,

More information

Three-Dimensional Inversion Rendering

Three-Dimensional Inversion Rendering Image Presentation Three-Dimensional Inversion Rendering New Sonographic Technique and Its Use in Gynecology Ilan E. Timor-Tritsch, MD, RDMS, na Monteagudo, MD, RDMS, Tanya Tsymbal,, RDMS, Irina Strok,

More information

Ultrasound in the First Trimester of Pregnancy. Elizabeth Lipson, HMS III

Ultrasound in the First Trimester of Pregnancy. Elizabeth Lipson, HMS III Ultrasound in the First Trimester of Pregnancy Elizabeth Lipson, HMS III First Trimester Sonography Localization of Gestational Sac Intrauterine vs. ectopic Identification of abnormalities Embryonic demise

More information

LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD

LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD 2 Outline Genetics 101: Basic Concepts and Myth Busting Inheritance Patterns

More information

Effects of Pregnancy & Delivery on Pelvic Floor

Effects of Pregnancy & Delivery on Pelvic Floor Effects of Pregnancy & Delivery on Pelvic Floor 吳 銘 斌 M.D., Ph.D. 財 團 法 人 奇 美 醫 院 婦 產 部 婦 女 泌 尿 暨 骨 盆 醫 學 科 ; 台 北 醫 學 大 學 醫 學 院 婦 產 學 科 ; 古 都 府 城 台 南 Introduction Pelvic floor disorders (PFDs) include

More information

Parvovirus B19 Infection in Pregnancy

Parvovirus B19 Infection in Pregnancy Parvovirus B19 Infection in Pregnancy Information Pack Parvovirus B19 Infection in Pregnancy Information Booklet CONTENTS: THE VIRUS page 3 CLINICAL MANIFESTATIONS page 6 DIAGNOSIS page 8 PATIENT MANAGEMENT

More information

Effect of incorrect gestational dating on Down s syndrome and neural tube risk assessment

Effect of incorrect gestational dating on Down s syndrome and neural tube risk assessment Original Article Ann Clin Biochem 2001; 38: 230±234 Effect of incorrect gestational dating on Down s syndrome and neural tube risk assessment S N Millner From the Department of Pathology, University of

More information

Evaluation of cardiotocographic and cord blood changes in induced labor with dinoprostone and misoprostol

Evaluation of cardiotocographic and cord blood changes in induced labor with dinoprostone and misoprostol International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pandey K et al. Int J Reprod Contracept Obstet Gynecol. 2014 Mar;3(1):199-203 www.ijrcog.org pissn 2320-1770 eissn 2320-1789

More information

RESEARCH ARTICLE. Epidemiology of Hydatidiform Moles in a Tertiary Hospital in Thailand over Two Decades: Impact of the National Health Policy

RESEARCH ARTICLE. Epidemiology of Hydatidiform Moles in a Tertiary Hospital in Thailand over Two Decades: Impact of the National Health Policy RESEARCH ARTICLE Epidemiology of Hydatidiform Moles in a Tertiary Hospital in Thailand over Two Decades: Impact of the National Health Policy Varangkana Wairachpanich 1, Sompop Limpongsanurak 1, Ruangsak

More information

Vaginal bleeding after midpregnancy

Vaginal bleeding after midpregnancy Late Pregnancy Bleeding ELLEN SAKORNBUT, M.D., Family Health Center of Waterloo, Waterloo, Iowa LAWRENCE LEEMAN, M.D., M.P.H., University of New Mexico, Albuquerque, New Mexico PATRICIA FONTAINE, M.D.,

More information

The quadruple test screening for Down s syndrome and spina bifida

The quadruple test screening for Down s syndrome and spina bifida The quadruple test screening for Down s syndrome and spina bifida This leaflet provides information about a blood test to check for Down s syndrome and spina bifida. This test is available to you between

More information

your questions answered the reassurance of knowing A guide for parents-to-be on noninvasive prenatal testing.

your questions answered the reassurance of knowing A guide for parents-to-be on noninvasive prenatal testing. your questions answered the reassurance of knowing A guide for parents-to-be on noninvasive prenatal testing. Accurate answers about your baby s health simply, safely, sooner. What is the verifi Prenatal

More information

Rural Health Advisory Committee s Rural Obstetric Services Work Group

Rural Health Advisory Committee s Rural Obstetric Services Work Group Rural Health Advisory Committee s Rural Obstetric Services Work Group March 15 th webinar topic: Rural Obstetric Patient and Community Issues Audio: 888-742-5095, conference code 6054760826 Rural Obstetric

More information

Introduction to Ultrasound for Obstetrics and Gynecology, 2 nd Session: Post-training report

Introduction to Ultrasound for Obstetrics and Gynecology, 2 nd Session: Post-training report Introduction to Ultrasound for Obstetrics and Gynecology, 2 nd Session: Post-training report From May 19 22 nd, 2009, the 2 nd session of Introduction to Ultrasound for Obstetrics and Gynecology was held

More information

Outcome of Patients with an Indeterminate Emergency Department First-trimester Pelvic Ultrasound to Rule Out Ectopic Pregnancy

Outcome of Patients with an Indeterminate Emergency Department First-trimester Pelvic Ultrasound to Rule Out Ectopic Pregnancy 912 Tayal et al. d INDETERMINATE US AND ECTOPIC PREGNANCY Outcome of Patients with an Indeterminate Emergency Department First-trimester Pelvic Ultrasound to Rule Out Ectopic Pregnancy Abstract Vivek S.

More information

Distortions in Fetal Growth Standards

Distortions in Fetal Growth Standards Pediat. Res. 12: 987-991 (1978) Fetus fetal growth retardation fetal growth standards Distortions in Fetal Growth Standards RICHARD L. NAEYE"" AND JOSEPH B. DIXON Department of Pathology and Research Computing

More information

This Protocol is adapted from the University of Colorado Protocol dated August 26, 2009.

This Protocol is adapted from the University of Colorado Protocol dated August 26, 2009. Protocol for Post-Placental IUD insertion July 14, 2010 This Protocol is adapted from the University of Colorado Protocol dated August 26, 2009. Background Post-placental intrauterine device (IUD) insertion

More information

Guide to Biostatistics

Guide to Biostatistics MedPage Tools Guide to Biostatistics Study Designs Here is a compilation of important epidemiologic and common biostatistical terms used in medical research. You can use it as a reference guide when reading

More information

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA Breast Imaging Made Brief and Simple Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA What women are referred for breast imaging? Two groups of women are referred for

More information

Executive summary. Current prenatal screening

Executive summary. Current prenatal screening Executive summary Health Council of the Netherlands. NIPT: dynamics and ethics of prenatal screening. The Hague: Health Council of the Netherlands, 2013; publication no. 2013/34. In recent years, new tests

More information

Clinical Policy Title: Home uterine activity monitoring

Clinical Policy Title: Home uterine activity monitoring Clinical Policy Title: Home uterine activity monitoring Clinical Policy Number: 12.01.01 Effective Date: August 19, 2015 Initial Review Date: July 17, 2013 Most Recent Review Date: July 15, 2015 Next Review

More information

Birth Defects Monitoring in Japan -Possible Effects of Environmental Endocrine Disrupters-

Birth Defects Monitoring in Japan -Possible Effects of Environmental Endocrine Disrupters- Birth Defects Monitoring in Japan -Possible Effects of Environmental Endocrine Disrupters- Fumiki Hirahara Yokohama City University School of Medicine Thank you, Paul. It is my great pleasure to be here

More information

Understanding Your Risk of Ovarian Cancer

Understanding Your Risk of Ovarian Cancer Understanding Your Risk of Ovarian Cancer A WOMAN S GUIDE This brochure is made possible through partnership support from Project Hope for Ovarian Cancer Research and Education. Project HOPE FOR OVARIAN

More information

Corporate Reimbursement Policy

Corporate Reimbursement Policy Corporate Reimbursement Policy Guidelines for Global Maternity Reimbursement File Name: Origination: Last Review: Next Review: guidelines_for_global_maternity_reimbursement 10/2003 7/2016 7/2017 Description

More information

Original Article A 5 year review of pregnancy outcome and interval to delivery after cervical cerclage in north-eastern Nigeria

Original Article A 5 year review of pregnancy outcome and interval to delivery after cervical cerclage in north-eastern Nigeria International Journal of Medicine and Biomedical Research Volume 3 Issue 1 January April 2014 www.ijmbr.com Michael Joanna Publications Original Article A 5 year review of pregnancy outcome and interval

More information

Lecture 12a: Complications of Pregnancy

Lecture 12a: Complications of Pregnancy This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Regions Hospital Delineation of Privileges Certified Nurse Midwife

Regions Hospital Delineation of Privileges Certified Nurse Midwife Regions Hospital Delineation of Privileges Certified Nurse Midwife Applicant s Name: Last First M. Instructions: Place a check-mark where indicated for each core group you are requesting. Review education

More information

Uterus myomatosus. 10-May-15. Clinical presentation. Incidence. Causes? 3 out of 4 women. Growth rate vary. Most common solid pelvic tumor in women

Uterus myomatosus. 10-May-15. Clinical presentation. Incidence. Causes? 3 out of 4 women. Growth rate vary. Most common solid pelvic tumor in women Uterus myomatosus A.J. Henriquez March 14, 2015 Uterus myomatosus Definition, incidence, clinical presentation and diagnosis. New FIGO classification for uterine leiomyomas Brief description on treatment

More information

8/13/2014. Blood, Sweat (and Tears): Delayed Cord Clamping and Delivery Room Temperature. Delayed Cord Clamping

8/13/2014. Blood, Sweat (and Tears): Delayed Cord Clamping and Delivery Room Temperature. Delayed Cord Clamping 8/13/2014 Blood, Sweat (and Tears): Delayed Cord Clamping and Delivery Room Temperature James F. Smith, Jr., MD Professor and Chair Obstetrics and Gynecology Creighton University School of Medicine The

More information

Maj Alison Baum. R3, Nellis FMR

Maj Alison Baum. R3, Nellis FMR Maj Alison Baum R3, Nellis FMR What are some of your thoughts about birth plans? http://www.youtube.com/watch?v=hh62v0c xf04 Labor: Pain management wishes Doulas Episiotomy Intermittent fetal monitoring

More information

Disclosure. Objectives 2/21/2016

Disclosure. Objectives 2/21/2016 Recurrent Pregnancy Loss: The myths, the controversies and the evidence Mamie McLean, MD Assistant Professor Reproductive Endocrinology and Infertility University of Alabama at Birmingham Disclosure I

More information

3 Summary of clinical applications and limitations of measurements

3 Summary of clinical applications and limitations of measurements CA125 (serum) 1 Name and description of analyte 1.1 Name of analyte Cancer Antigen 125 (CA125) 1.2 Alternative names Mucin 16 1.3 NLMC code To follow 1.4 Description of analyte CA125 is an antigenic determinant

More information

The 11 13 +6 weeks scan

The 11 13 +6 weeks scan The 11 13 +6 weeks scan Kypros H. Nicolaides The 11 13 +6 weeks scan Fetal Medicine Foundation, London 2004 Dedication to Herodotos & Despina Contents Introduction 1. First trimester diagnosis of chromosomal

More information

Hindrik Vondeling Department of Health Economics University of Southern Denmark Odense, Denmark

Hindrik Vondeling Department of Health Economics University of Southern Denmark Odense, Denmark Health technology assessment: an introduction with emphasis on assessment of diagnostic tests Hindrik Vondeling Department of Health Economics University of Southern Denmark Odense, Denmark Outline λ Health

More information

Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease

Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease International Journal of Clinical Medicine, 2011, 2, 264-268 doi:10.4236/ijcm.2011.23042 Published Online July 2011 (http://www.scirp.org/journal/ijcm) Incidence of Incidental Thyroid Nodules on Computed

More information